Crescent Biopharma (CBIO) Metrics: History & Chart

Crescent Biopharma, Inc.(CBIO)

Biotechnology · Waltham, MA

$14.28+0.34 (+2.44%)

Delayed quote: Oct 6, 2026, 10:15 AM EDT

About Crescent Biopharma, Inc.

Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.

Waltham, MA

44 employees

crescentbiopharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Joshua T. Brumm

View full financials

Third-Party DCF Estimate (FMP)	$20.78
Price Gap vs Third-Party Estimate	+49.07%

7D Total Return	-4.06%
30D Total Return	-33.24%
YTD Total Return	+17.54%
1Y Total Return	+18.94%
3Y Total Return	-90.25%
5Y Total Return	-75.30%
10Y Total Return	-92.61%
15Y Total Return	N/A
20Y Total Return	N/A

2026	+17.54%
2025	-52.37%
2024	-89.45%
2023	-15.92%
2022	+580.57%
2021	-61.70%
2020

CAGR TTM	+18.84%
CAGR 3Y	-53.97%
CAGR 5Y	-24.40%
CAGR 10Y	-22.94%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

CBIO Valuation Metrics

CBIO Stock Price Metrics

CBIO Dividend Metrics

CBIO Growth Rate Metrics

CBIO Discounted Cash Flow Metrics

CBIO Returns By Period

CBIO Yearly Returns

CBIO Average Annual Returns By Period (CAGR)

CBIO Revenue Metrics

CBIO PE Ratio Metrics

CBIO PS Ratio Metrics

CBIO PB Ratio Metrics

CBIO Price to Free Cash Flow Ratio Metrics

CBIO Debt to Equity Ratio Metrics

CBIO PEG Ratio Metrics

CBIO FCF Yield

CBIO Earnings Yield

CBIO EBITDA Yield

CBIO OCF Yield

CBIO EV/EBIT Ratio Metrics

CBIO EV/EBITDA Ratio Metrics

CBIO EV/Assets Ratio Metrics

CBIO EV/Sales Ratio Metrics

CBIO Current Ratio Metrics

CBIO Quick Ratio Metrics

CBIO ROIC Metrics

CBIO Return on Assets Metrics

CBIO Return on Equity Metrics

CBIO Net Profit Margin Metrics

CBIO Gross Profit Margin Metrics

CBIO Tax Rate Metrics

PS Ratio	35.82
PS Ratio Avg TTM	41.46
PS Ratio Avg 3Y	929.49
Current VS TTM Avg	-13.61%
Current VS 3Y Avg	-96.15%
Current VS 5Y Avg	-95.18%

PB Ratio	2.67
PB Ratio Avg TTM	2.16
PB Ratio Avg 3Y	2.16
Current VS TTM Avg	+23.78%
Current VS 3Y Avg	+23.49%
Current VS 5Y Avg	+47.70%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.01
Debt/Equity Ratio Avg TTM	0.01
Debt/Equity Ratio Avg 3Y	0.02
Current VS TTM Avg	-15.40%
Current VS 3Y Avg	-42.14%
Current VS 5Y Avg	-50.27%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.40
Ev/Assets Ratio Avg TTM	1.11
Ev/Assets Ratio Avg 3Y	1.15
Current VS TTM Avg	+26.22%
Current VS 3Y Avg	+21.80%
Current VS 5Y Avg	+32.12%

Ev/Sales Ratio	21.50
Ev/Sales Ratio Avg TTM	23.82
Ev/Sales Ratio Avg 3Y	126.20
Current VS TTM Avg	-9.75%
Current VS 3Y Avg	-82.96%
Current VS 5Y Avg	-93.86%

Current Ratio	9.66
Current Ratio Avg TTM	9.17
Current Ratio Avg 3Y	6.86
Current VS TTM Avg	+5.35%
Current VS 3Y Avg	+40.81%
Current VS 5Y Avg	+30.81%

Quick Ratio	9.66
Quick Ratio Avg TTM	9.17
Quick Ratio Avg 3Y	6.86
Current VS TTM Avg	+5.35%
Current VS 3Y Avg	+40.81%
Current VS 5Y Avg	+30.81%

ROIC	(102.59%)
ROIC Avg 3Y	(122.59%)
ROIC Avg 5Y	(85.95%)
Current VS 3Y Avg	+16.31%
Current VS 5Y Avg	-19.36%
Current VS 10Y Avg	-66.30%

ROA	(89.18%)
ROA Avg TTM	(18.84%)
ROA Avg 3Y	(25.47%)
Current VS TTM Avg	-373.37%
Current VS 3Y Avg	-250.10%
Current VS 5Y Avg	-355.86%

ROE	(99.83%)
ROE Avg TTM	(75.66%)
ROE Avg 3Y	(94.83%)
Current VS TTM Avg	-31.94%
Current VS 3Y Avg	-5.28%
Current VS 5Y Avg	-17.73%

Net Profit Margin	(1371.51%)
Net Profit Margin Avg TTM	(618.59%)
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	-121.71%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	-609.49%

Gross Profit Margin	100.00%
Gross Pft Margin Avg TTM	40.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	+150.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	+200.00%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.19%
Tax Rate Avg 5Y	0.19%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%
Current VS 10Y Avg	-100.00%